Tonix Pharmaceuticals Holding Corp (TNXP)
0.1835
+0.01
(+7.25%)
USD |
NASDAQ |
May 03, 16:00
0.1723
-0.01
(-6.10%)
After-Hours: 20:00
Tonix Pharmaceuticals Free Cash Flow: -109.90M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -109.90M |
| September 30, 2023 | -114.09M |
| June 30, 2023 | -121.25M |
| March 31, 2023 | -131.65M |
| December 31, 2022 | -146.20M |
| September 30, 2022 | -167.30M |
| June 30, 2022 | -155.64M |
| March 31, 2022 | -140.56M |
| December 31, 2021 | -110.86M |
| September 30, 2021 | -81.24M |
| June 30, 2021 | -79.85M |
| March 31, 2021 | -69.37M |
| December 31, 2020 | -57.13M |
| September 30, 2020 | -45.37M |
| June 30, 2020 | -32.72M |
| March 31, 2020 | -27.38M |
| December 31, 2019 | -26.70M |
| September 30, 2019 | -26.84M |
| June 30, 2019 | -25.08M |
| March 31, 2019 | -25.85M |
| December 31, 2018 | -23.98M |
| September 30, 2018 | -22.08M |
| June 30, 2018 | -22.24M |
| March 31, 2018 | -21.11M |
| December 31, 2017 | -19.13M |
| Date | Value |
|---|---|
| September 30, 2017 | -19.64M |
| June 30, 2017 | -22.99M |
| March 31, 2017 | -26.62M |
| December 31, 2016 | -37.38M |
| September 30, 2016 | -43.90M |
| June 30, 2016 | -47.87M |
| March 31, 2016 | -49.26M |
| December 31, 2015 | -42.77M |
| September 30, 2015 | -39.15M |
| June 30, 2015 | -31.80M |
| March 31, 2015 | -28.15M |
| December 31, 2014 | -23.16M |
| September 30, 2014 | -18.35M |
| June 30, 2014 | -16.21M |
| March 31, 2014 | -11.24M |
| December 31, 2013 | -8.532M |
| September 30, 2013 | -6.500M |
| June 30, 2013 | -4.931M |
| March 31, 2013 | -5.333M |
| December 31, 2012 | -5.749M |
| September 30, 2012 | -5.71M |
| June 30, 2012 | -4.966M |
| March 31, 2012 | -4.034M |
| December 31, 2011 | -2.640M |
| September 30, 2011 | -2.394M |
Free Cash Flow Range, Past 5 Years
-167.30M
Minimum
Sep 2022
-25.08M
Maximum
Jun 2019
-87.85M
Average
-81.24M
Median
Sep 2021
Free Cash Flow Benchmarks
| PetVivo Holdings Inc | -7.600M |
| Acurx Pharmaceuticals Inc | -9.801M |
| Kezar Life Sciences Inc | -83.46M |
| Allakos Inc | -117.07M |
| RAPT Therapeutics Inc | -98.17M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.34M |
| Cash from Investing (Quarterly) | -0.431M |
| Cash from Financing (Quarterly) | 40.71M |
| Free Cash Flow Per Share (Quarterly) | -0.3886 |
| Free Cash Flow to Equity (Quarterly) | -31.69M |
| Free Cash Flow Yield | -2.53K% |